Wakelam, who died of a suspected COVID-19 infection, is remembered for his research on the physiological function of lipids.

A study in mice suggests serotonin release underlies the drug’s prosocial effects while dopamine mediates the rewarding properties that drive its potential for abuse.

A study of 11 drugs now in clinical trials suggests they do kill cancer cells—but through a different mechanism than indicated in previous research.

An injectable biomaterial calls cancer drugs to tumor sites in mice.

The drug promotes and sustains brain cell connectivity in mice, reversing the effects of chronic stress.

The monoclonal antibody, known as mAb114, is likely to be used in the current Ebola outbreak in DRC.

Multidrug combinations lead to better results for cancer patients, but efficiently identifying them is proving difficult.

Researchers use several different strategies to deliver a one-two punch.

The Scientist speaks with a clinical toxicologist to discuss how the supplement acts in the brain and what the agency's declaration means for research.